IP Library Granted Patent US 11,547,418
Granted Patent B2
US 11,547,418 · App. 16/678,524 · Granted Jan 10, 2023

Embolic implant and method of use

Inventors: Brian M. Strauss (Trabuco Canyon, CA); Jeffrey J. Valko (San Clemente, CA); Jay A. Lenker (Laguna Beach, CA); Robert A. Pecor (Irvine, CA); Peter Barker (Irvine, CA); Maricruz Castaneda (Irvine, CA)
Assignee: COVIDIEN LP
A61B17/12172A61B17/12031A61B17/12036A61B17/12109A61B17/12113A61B17/12145A61B17/12154A61F2/91A61L31/022A61L31/10A61L31/146A61B2017/00526A61B2017/00539A61B2017/00544A61B2017/00557A61B2017/00867A61B2017/12054A61B2017/12063A61B2017/12068A61B2017/12077A61B2017/12081A61B2017/12086A61B2017/12095A61F2002/823A61F2220/0058A61F2230/0071A61F2230/0076A61L2400/04A61L2400/14A61L2400/16A61L2420/04A61L2430/36
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,547,418
App. No.
16/678,524
Granted
Jan 10, 2023
Kind
B2
Abstract

A parent artery occlusion (PAO) device which provides for immediate occlusion of a cerebral artery to isolate a defect. The PAO device includes a self-expanding wire-frame prolate structure which is partially covered with an ePTFE membrane.

Claims (37)

1. A system comprising:

a delivery member; and

an embolic implant comprising:

a wire frame structure comprising:

a pair of opposing zigzag segments including a plurality of elements, each element of the plurality of elements defining an open end and a closed end opposite the open end, and each element of the plurality of elements being joined at the respective open end to another element via struts to form a central portion of the wire frame structure, the closed ends of the elements pointing proximally or distally away from a longitudinal center of the wire frame structure;

a first plurality of longitudinally oriented struts extending from proximally pointing closed ends of the elements, the first plurality of longitudinally oriented struts being joined together at a proximal end of the wire frame structure; and

a second plurality of longitudinally oriented struts extending from distally pointing closed ends of the elements, the second plurality of longitudinally oriented struts being joined together at a distal end of the embolic implant;

a blood impermeable membrane covering at least a part of the wire frame structure and extending from the proximal end of the wire frame structure to at least distal to the longitudinal center of the wire frame structure; and

a detachment joint configured to releasably join a proximal end of the wire frame structure to the delivery member.

2. The system of claim 1 , wherein the plurality of elements comprises V-shaped elements.

3. The system of claim 1 , wherein the plurality of elements comprises U-shaped elements.

4. The system of claim 1 , wherein the plurality of elements comprises sinusoidally curved elements.

5. The system of claim 1 , wherein the first plurality of longitudinally oriented struts are joined together near a radial center of the wire frame structure and the second plurality of longitudinally oriented struts are joined together near the radial center of the wire frame structure.

6. The system of claim 1 , further comprising:

a first ring joining the first plurality of longitudinally oriented struts together at the proximal end of the wire frame structure; and

a second ring joining the second plurality of longitudinally oriented struts together at the distal end of the wire frame structure.

7. The system of claim 1 , wherein the struts joining the elements are longitudinally displaced from each other.

8. The system of claim 1 , wherein the proximally pointing closed ends of the elements are not circumferentially aligned.

9. The system of claim 1 , wherein the blood impermeable membrane comprises a proximal facing surface and a circumferential facing surface, wherein at least the proximal facing surface is blood impermeable.

10. The system of claim 9 , wherein the proximal facing surface and the circumferential facing surface are blood impermeable.

11. The system of claim 1 , wherein the blood impermeable membrane is perforated with weep holes.

12. The system of claim 1 , wherein the blood impermeable membrane comprises expanded polytetrafluoroethylene (ePTFE).

13. The system of claim 1 , wherein the wire-frame structure is at least partially formed from a pseudoelastic metal alloy.

14. The system of claim 1 , wherein the wire frame structure is configured to expand from a compacted configuration to a fully expanded configuration, wherein when the wire frame structure is in the fully expanded configuration, the wire frame structure has a maximum diameter of about 5 millimeters, and when the wire frame structure is in the compacted configuration, the wire frame structure has a maximum diameter of less than about 0.6 mm.

15. The system of claim 1 , wherein the detachment joint comprises an electrolytic detachment joint.

16. The system of claim 1 , wherein the detachment joint comprises a detent configured to engage with the delivery member.

17. An embolic implant comprising:

a wire frame structure comprising:

a pair of opposing zigzag segments including a plurality of elements, each element of the plurality of elements defining an open end and being joined at the respective open end to another element via struts to form a central portion of the wire frame structure, the elements defining proximal or distal vertices pointing proximally or distally away from a longitudinal center of the wire frame structure;

a first plurality of longitudinally oriented struts extending from the proximally pointing vertices of the elements, the first plurality of longitudinally oriented struts being joined together at a proximal end of the wire frame structure; and

a second plurality of longitudinally oriented struts extending from the distally pointing vertices of the elements, the second plurality of longitudinally oriented struts being joined together at a distal end of the embolic implant; and

a blood impermeable membrane covering at least a part of the wire frame structure extending from the proximal end of the wire frame structure to at least distal to the longitudinal center of the wire frame structure; and

a detachment joint configured to releasably join a proximal end of the wire frame structure to a delivery member.

18. The embolic implant of claim 17 , wherein the plurality of elements comprises V-shaped elements.

19. The embolic implant of claim 17 , wherein the plurality of elements comprises U-shaped elements.

20. The embolic implant of claim 17 , wherein the plurality of elements comprises sinusoidally curved elements.

21. The embolic implant of claim 17 , wherein the struts joining the elements are longitudinally displaced from each other.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2019
From: STRAUSS, BRIAN; VALKO, JEFFREY J.; LENKER, JAY A.; PECOR, ROBERT A.; BARKER, PETER; CASTANEDA, MARICRUZ
To: REVERSE MEDICAL CORPORATION
Reel/Frame 050959/0950 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2019
From: REVERSE MEDICAL LLC
To: COVIDIEN LP
Reel/Frame 050960/0294 →
CHANGE OF NAME Recorded Nov 8, 2019
From: REVERSE MEDICAL CORPORATION
To: REVERSE MEDICAL LLC
Reel/Frame 050976/0563 →
Continuity (5)
Continuation 15072873 · Mar 17, 2016
Continuation 14171088 · Feb 3, 2014
Continuation 13483962 · May 30, 2012
Provisional Application 61493108 · Jun 3, 2011
Related Publication 20200069315A1 · Mar 5, 2020